Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02593968
What this trial is testing

Yallaferon in Chinese Population

Who this might be right for
HPV Infection
Lee's Pharmaceutical Limited 100
Testing effectiveness (Phase 2)Study completedNCT00024518
What this trial is testing

Interferon-Alpha for Diabetes Mellitus Type 1

Who this might be right for
Insulin-Dependent Diabetes Mellitus
The University of Texas Health Science Center, Houston 57
Testing effectiveness (Phase 2)Study completedNCT00050778
What this trial is testing

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genzyme, a Sanofi Company 334
Large-scale testing (Phase 3)Study completedNCT04846491
What this trial is testing

Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 475
Testing effectiveness (Phase 2)Study completedNCT02094443
What this trial is testing

Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

Who this might be right for
Hepatitis CLiver Disease
Debiopharm International SA 52
Not applicableUnknownNCT02336399
What this trial is testing

Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment

Who this might be right for
Chronic Hepatitis B
Beijing Ditan Hospital 420
Testing effectiveness (Phase 2)Study completedNCT01158534
What this trial is testing

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Renal Cell CancerStage IV Renal Cell Cancer
Case Comprehensive Cancer Center 17
Not applicableStudy completedNCT00455832
What this trial is testing

Influence of Ribavirin and Interferon on Semen Quality, IRIS Study

Who this might be right for
Sperm Motility (Focus of Study)
Foundation for Liver Research 23
Very early researchNot Yet RecruitingNCT07553767
What this trial is testing

Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection

Who this might be right for
Hepatocellular CarcinomaHEPATITIS B CHRONICHepatitis B Chronic Infection
Ningbo No.2 Hospital 156
Post-approval studies (Phase 4)Study completedNCT00491244
What this trial is testing

Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Taiwan University Hospital 377
Not applicableLooking for participantsNCT06696664
What this trial is testing

Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon

Who this might be right for
Chronic Hepatitis B
Minghui Li 120
Large-scale testing (Phase 3)Study completedNCT00211887
What this trial is testing

Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Fred Lublin 1,008
Large-scale testing (Phase 3)Study completedNCT00577993
What this trial is testing

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 210
Testing effectiveness (Phase 2)Study completedNCT04412863
What this trial is testing

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Vir Biotechnology, Inc. 84
Large-scale testing (Phase 3)Ended earlyNCT01866930
What this trial is testing

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Who this might be right for
Chronic Hepatitis C Infection
Bristol-Myers Squibb 453
Not applicableStudy completedNCT00422838
What this trial is testing

Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.

Who this might be right for
Hepatitis CLiverImmunology+1 more
Foundation for Liver Research 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07662278
What this trial is testing

RSIFN-co in Combination With Total Neo-adjuvant Therapy in Subjects With Mid-low Locally Advanced Rectal Cancer

Who this might be right for
Mid-low Locally Advanced Rectal Cancer
Sichuan Huiyang Life Science and Technology Corporation 90
Not applicableStudy completedNCT04376476
What this trial is testing

Host-pathogen Interactions During SARS-CoV-2 Infection

Who this might be right for
Infection, CoronavirusSevere Acute Respiratory Syndrome Coronavirus 2
Hospices Civils de Lyon 140
Testing effectiveness (Phase 2)Looking for participantsNCT05870475
What this trial is testing

Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV

Who this might be right for
Polycythemia Vera
Institute of Hematology & Blood Diseases Hospital, China 94
Not applicableStudy completedNCT02076841
What this trial is testing

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen

Who this might be right for
Relapsing-Remitting Multiple SclerosisClinical Isolated Syndrome (CIS)Multiple Sclerosis
Biogen 40
Next Page